BALTIMORE - FDG-PET and FDG-PET/CT do a good job in predicting the chances of recurrence and survival for patients with head and neck cancer within two years of completing chemotherapy treatment, ...
Five out of six patients in FDA authorized Expanded Access Program are showing a qualitative reduction in microglia activation (a key biomarker being observed) Foralumab to advance into Phase 2 human ...
A response-adapted approach to the treatment of patients with advanced Hodgkin's lymphoma de-escalates treatment after an early negative PET scan and intensifies treatment in those with a PET-positive ...
Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...
Gamma knife radiosurgery for melanoma/renal cell carcinoma brain metastases 1 -10 lesions with optimized margin dose: Improved tumor control and survival No significant financial relationships to ...
June 30, 2006 (San Diego) — False-positive results on positron emission tomography (PET) with computed tomography (CT) scans, which may suggest that there is a malignancy when in fact there is none, ...
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...
While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results. Adding Adcetris (brentuximab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results